Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Acta Paediatr ; 112(7): 1565-1573, 2023 07.
Article in English | MEDLINE | ID: mdl-36951625

ABSTRACT

AIM: To systematically review the clinical features and outcomes of paediatric patients developing neurological complications associated with a rotavirus infection. METHODS: A systematic literature review and meta-analysis was performed, including articles published from 1984 to 2020. Neurological complications were classified into four groups: encephalitis, cerebellitis, encephalo-cerebellitis and benign convulsions with mild gastroenteritis (CwG). RESULTS: Out of 68 reports that fulfilled the research criteria, 99 cases of CwG, 39 cases of encephalitis, 18 cases of encephalo-cerebellitis and five cases of cerebellitis were collected. Ninety-five patients were from Asia. Median age was 22 (IQR 14-29) months, and the children who developed CwG were significantly younger (19, IQR 12-24 months, p < 0.0001) than the others. Status epilepticus was observed in 23% and 5% of the encephalitis and CwG groups respectively. The most frequently described neuroimaging finding were lesions of the splenium of corpus callosum. Four deaths were reported in the encephalitis group, whereas no fatal events were described in the other groups. Among the surviving children, the encephalo-cerebellitis group showed the most severe long-term outcome. All cases of CwG recovered completely. CONCLUSION: Older age at diagnosis and the development of encephalo-cerebellitis are associated with a higher risk of long-term complications.


Subject(s)
Encephalitis , Gastroenteritis , Rotavirus Infections , Rotavirus , Humans , Child , Young Adult , Adult , Rotavirus Infections/complications , Rotavirus Infections/diagnosis , Gastroenteritis/complications , Seizures/etiology , Neuroimaging
2.
Eur J Neurol ; 25(3): 562-568, 2018 03.
Article in English | MEDLINE | ID: mdl-29281157

ABSTRACT

BACKGROUND AND PURPOSE: Serum neurofilaments are markers of axonal injury. We addressed their diagnostic and prognostic role in acute ischemic stroke (AIS) and transient ischemic attack (TIA). METHODS: Nested within a prospective cohort study, we compared levels of serum neurofilament light chain (sNfL) drawn within 24 h from symptom onset in patients with AIS or TIA. Patients without magnetic resonance imaging on admission were excluded. We assessed whether sNfL was associated with: (i) clinical severity on admission, (ii) diagnosis of AIS vs. TIA, (iii) infarct size on admission magnetic resonance diffusion-weighted imaging (MR-DWI) and (iv) functional outcome at 3 months. RESULTS: We analyzed 504 patients with AIS and 111 patients with TIA. On admission, higher National Institutes of Health Stroke Scale (NIHSS) scores were associated with higher sNfL: NIHSS score < 7, 13.1 pg/mL [interquartile range (IQR), 5.3-27.8]; NIHSS score 7-15, 16.7 pg/mL (IQR, 7.4-34.9); and NIHSS score > 15, 21.0 pg/mL (IQR, 9.3-40.4) (P = 0.01). Compared with AIS, patients with TIA had lower sNfL levels [9.0 pg/mL (95% confidence interval, 4.0-19.0) vs. 16.0 pg/mL (95% confidence interval, 7.3-34.4), P < 0.001], also after adjusting for age and NIHSS score (P = 0.006). Among patients with AIS, infarct size on admission MR-DWI was not associated with sNfL, either in univariate analysis (P = 0.15) or after adjusting for age and NIHSS score on admission (P = 0.56). Functional outcome 3 months after stroke was not associated with sNfL after adjusting for established predictors. CONCLUSIONS: In conclusion, among patients admitted within 24 h of AIS or TIA onset, admission sNfL levels were associated with clinical severity on admission and TIA diagnosis, but not with infarct size on MR-DWI acquired on admission or functional outcome at 3 months.


Subject(s)
Brain Ischemia/blood , Ischemic Attack, Transient/blood , Neurofilament Proteins/blood , Outcome Assessment, Health Care , Stroke/blood , Aged , Brain Ischemia/diagnosis , Brain Ischemia/therapy , Female , Humans , Ischemic Attack, Transient/diagnosis , Ischemic Attack, Transient/therapy , Magnetic Resonance Imaging , Male , Middle Aged , Prospective Studies , Severity of Illness Index , Stroke/diagnosis , Stroke/therapy
3.
Eur J Neurol ; 22(5): 859-65, e61, 2015 May.
Article in English | MEDLINE | ID: mdl-25712171

ABSTRACT

BACKGROUND AND PURPOSE: To determine the frequency of new ischaemic or hemorrhagic brain lesions on early follow-up magnetic resonance imaging (MRI) in patients with cervical artery dissection (CAD) and to investigate the relationship with antithrombotic treatment. METHODS: This prospective observational study included consecutive CAD patients with ischaemic or non-ischaemic symptoms within the preceding 4 weeks. All patients had baseline brain MRI scans at the time of CAD diagnosis and follow-up MRI scans within 30 days thereafter. Ischaemic lesions were detected by diffusion-weighted imaging (DWI), intracerebral bleeds (ICBs) by paramagnetic-susceptible sequences. Outcome measures were any new DWI lesions or ICBs on follow-up MRI scans. Kaplan-Meier statistics and calculated odds ratios with 95% confidence intervals were used for lesion occurrence, baseline characteristics and type of antithrombotic treatment (antiplatelet versus anticoagulant). RESULTS: Sixty-eight of 74 (92%) CAD patients were eligible for analysis. Median (interquartile range) time interval between baseline and follow-up MRI scans was 5 (3-10) days. New DWI lesions occurred in 17 (25%) patients with a cumulative 30-day incidence of 41.3% (standard error 8.6%). Occurrence of new DWI lesions was associated with stroke or transient ischaemic attack at presentation [7.86 (2.01-30.93)], occlusion of the dissected vessel [4.09 (1.24-13.55)] and presence of DWI lesions on baseline MRI [6.67 (1.70-26.13)]. The type of antithrombotic treatment had no impact either on occurrence of new DWI lesions [1.00 (0.32-3.15)] or on functional 6-month outcome [1.27 (0.41-3.94)]. No new ICBs were observed. CONCLUSION: New ischaemic brain lesions occurred in a quarter of CAD patients, independently of the type of antithrombotic treatment. MRI findings could potentially serve as surrogate outcomes in pilot treatment trials.


Subject(s)
Anticoagulants/therapeutic use , Aortic Dissection/epidemiology , Brain Ischemia/epidemiology , Cerebral Hemorrhage/epidemiology , Platelet Aggregation Inhibitors/therapeutic use , Adult , Anticoagulants/adverse effects , Brain Ischemia/chemically induced , Cerebral Hemorrhage/chemically induced , Diffusion Magnetic Resonance Imaging , Female , Follow-Up Studies , Humans , Incidence , Male , Middle Aged , Platelet Aggregation Inhibitors/adverse effects
4.
Ther Umsch ; 69(9): 536-42, 2012 Sep.
Article in German | MEDLINE | ID: mdl-22923357

ABSTRACT

The risk to have a stroke during childhood is at least as frequent as to suffer from a brain tumour. Unlike adults, in whom ischaemic strokes overweigh haemorrhagic strokes, ischaemic and haemorrhagic strokes are equally frequent in children, occurring with an incidence of 2 - 3/100'000 children/year. Even though the clinical presentation of arterial-ischaemic stroke in children (pedAIS) is similar to adults, time to diagnosis is longer. The delay to diagnosis is mainly explained by the low index of suspicion of both the general population and the medical personnel, a broad range of differential diagnoses, and the fact that diagnostic imaging in children often requires sedation, which is not always readily available. PedAIS is a multiple risk problem, usually occurring due to a combination of risk factors, such as infectious diseases, dehydration, trauma or an underlying condition such as congenital heart disease. Still little is known about the appropriate management of pedAIS. Supportive measures are considered to be the mainstay of therapy. The use of antithrombotic medication depends on pedAIS aetiology. In an ongoing multicenter trial, the safety and effectiveness of thrombolysis are currently being investigated. PedAIS carries an important mortality and morbidity, with neurological and neuropsychological deficits persisting in two thirds of the affected children.


Subject(s)
Stroke/etiology , Child , Conscious Sedation , Cross-Sectional Studies , Delayed Diagnosis , Diagnosis, Differential , Diagnostic Imaging , Humans , Incidence , Neurologic Examination , Prognosis , Risk Factors , Stroke/diagnosis , Stroke/epidemiology , Stroke/therapy
5.
Praxis (Bern 1994) ; 101(5): 317-24, 2012 Feb 29.
Article in German | MEDLINE | ID: mdl-22377979

ABSTRACT

The general practitioner has an important role in the acute management and during the rehabilitation process of children after a traumatic head injury. Latest research shows that sequelae may occur even after a mild head injury without loss of consciousness. Recognizing the warning signs and symptoms after a head injury allows the general practitioner to counsel the child and parents in secondary prevention, particularly in order to avoid any further head injury during the recovery phase. Under the supervision of the general practitioner, a gradual progressive return to the child's everyday activities optimizes the chances of a rapid and complete recovery.


Subject(s)
Craniocerebral Trauma/diagnosis , Adolescent , Aftercare , Athletic Injuries/classification , Athletic Injuries/diagnosis , Athletic Injuries/therapy , Brain Concussion/classification , Brain Concussion/diagnosis , Brain Concussion/therapy , Child , Child, Preschool , Cooperative Behavior , Craniocerebral Trauma/classification , Craniocerebral Trauma/therapy , Emergency Medical Services , General Practice , Glasgow Coma Scale , Humans , Infant , Interdisciplinary Communication , Prognosis
6.
Am J Med Genet A ; 155A(8): 1964-8, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21739569

ABSTRACT

Monosomy 1p36 results from heterozygous deletions of the terminal short chromosome 1 arm, the most common terminal deletion in humans. The microdeletion is split in two usually non-overlapping and clinically distinct classical distal and proximal 1p36 monosomy syndromes. Using comparative genome hybridization, MLPA and qPCR we identified the largest contiguous ∼16 Mb terminal 1p36 deletion reported to date. It covers both distal and proximal regions, causes a neonatally lethal variant with virtually exclusive features of distal 1p36 monosomy, highlighting the key importance of the gene-rich distal region for the "compound" 1p36 phenotype and a threshold deletion-size effect for haplo-lethality.


Subject(s)
Abnormalities, Multiple/genetics , Chromosome Deletion , Chromosome Disorders/diagnosis , Chromosomes, Human, Pair 1/genetics , Agenesis of Corpus Callosum , Brain Diseases/genetics , Chromosome Breakpoints , Chromosome Disorders/genetics , Comparative Genomic Hybridization , Fatal Outcome , Female , Gene Deletion , Genetic Association Studies , Humans , Infant, Newborn , Phenotype , Polyhydramnios/diagnosis , Pregnancy , Premature Birth , Respiratory Insufficiency/diagnosis , Septum Pellucidum/abnormalities
SELECTION OF CITATIONS
SEARCH DETAIL
...